MAC Clinical Research’s Post

In the latest #TalkClinicalTrials blog, learn more about the barriers to #type1diabetes clinical trial participation and JDRF/FRDJ Canada's new T1D Clinical Trials Finder. Read the blog post here: https://bit.ly/48SNR6D #ClinicalTrials #ClinicalTrialParticipation

📢Let's do all that we can to ensure the voices of study sites don't get lost in the broader clinical trial operations. It is time to integrate the site's perspective into the assessment of performance for a more realistic, holistic, and effective evaluation and operation of clinical trials.📢 Key Take-aways: -Challenges in communication and collaboration in CRO performance -Real-world examples of overlooked site concerns -The underestimated value to the site's perspective in CRO performance #CRO #ClinicalTrials #ClinicalStudy https://lnkd.in/gMd9zmkN.

Somewhat behind the times, but I saw this informative quick read about the state of clinical trials in the UK. We already ask our NHS GP's to do quite a lot, but embedding clinical trials into GP practice really is the gold standard. And the NHS's design means its uniquely well-placed to be a clinical trial powerhouse. The benefits of the UK regaining its ground as a global leader in clinical trials are clear for patients, research, and investment into the UK. In fact, this well-trodden ground for Public Policy Projects, just check out our research library and find our Clinical Research Coalition write ups (https://lnkd.in/eJ8AMTg5). But there is another argument for increased clinical trial participation that I want to make: it could help reduce NHS waiting lists. Druggable pathways typically speed up the patient journey, and when doctors, clinicians, and patients know there is a drug available for them (even a drug in trial phases), the patient journey from diagnosis to treatment accelerates. Faster pathways are clearly beneficial for patients in need of treatment, and the effects of faster pathways across the country could mean at-scale reductions in treatment waiting times. Additional trials may add some weight to the system, but pharma companies and other partners often provide resources, such as funding, staff, and additional equipment. In just five years, the UK has dropped from 4th to 10th in terms of global contributions to clinical trials. Reversing this trend will be hard work, but the benefits will be wide-ranging. https://lnkd.in/eY8JNUrG

Our clinical trial data is only as valuable as the patient populations we recruit. To ensure the success of their studies, Merck has implemented measures to overcome common barriers to clinical trial recruitment. Now is the time for all companies to proactively address these issues for the benefit of all our studies. #clinicaltrials #recruitment #healthcare https://lnkd.in/eEsKMyPs

Since 2012, the number of #clinicaltrials conducted in the UK has decreased by half, according to GlobalData’s clinical trials database. #Brexit might be partly to blame, but experts agree—it’s not that simple. Clinical Trials Arena explores this decline in UK-based clinical studies as well as the steps the government could take to increase trial activity: https://lnkd.in/e8gmc4NK?utmcampaign=BoostPostWebsite%20VisitsAug%2016,%202023,%2015:10:33&utmcampaign=BoostPostWebsite%20VisitsAug%2016,%202023,%2015:10:33&utmcampaign=BoostPostWebsite%20VisitsAug%2016,%202023,%2015:10:33&utmcampaign=BoostPostWebsite%20VisitsAug%2016,%202023,%2015:10:33&utmcampaign=BoostPostWebsite%20VisitsAug%2016,%202023,%2015:10:33&utmcampaign=BoostPostWebsite%20VisitsAug%2016,%202023,%2015:10:33&utmcampaign=BoostPostWebsite%20VisitsAug%2016,%202023,%2015:10:33&utmcampaign=BoostPostWebsite%20VisitsAug%2016,%202023,%2015:10:33&utmcampaign=BoostPostWebsite%20VisitsAug%2016,%202023,%2015:10:33&utmcampaign=BoostPostWebsite%20VisitsAug%2016,%202023,%2015:10:33&utmcampaign=BoostPostWebsite%20VisitsAug%2016,%202023,%2015:10:33&utmcampaign=BoostPostWebsite%20VisitsAug%2016,%202023,%2015:10:33&utmsource=linkedin&utmsource=linkedin&utmsource=linkedin&utmsource=linkedin&utmsource=linkedin&utmsource=linkedin&utmsource=linkedin&utmsource=linkedin&utmsource=linkedin&utmsource=linkedin&utmsource=linkedin&utmsource=linkedin&utmmedium=paid&utmmedium=paid&utmmedium=paid&utmmedium=paid&utmmedium=paid&utmmedium=paid&utmmedium=paid&utmmedium=paid&utmmedium=paid&utmmedium=paid&utmmedium=paid&utmmedium=paid&hsaacc=506280771&hsaacc=506280771&hsaacc=506280771&hsaacc=506280771&hsaacc=506280771&hsaacc=506280771&hsaacc=506280771&hsaacc=506280771&hsaacc=506280771&hsaacc=506280771&hsaacc=506280771&hsaacc=506280771&hsacam=664708403&hsacam=664708403&hsacam=664708403&hsacam=664708403&hsacam=664708403&hsacam=664708403&hsacam=664708403&hsacam=664708403&hsacam=664708403&hsacam=664708403&hsacam=664708403&hsacam=664708403&hsagrp=274867863&hsagrp=274867863&hsagrp=274867863&hsagrp=274867863&hsagrp=274867863&hsagrp=274867863&hsagrp=274867863&hsagrp=274867863&hsagrp=274867863&hsagrp=274867863&hsagrp=274867863&hsagrp=274867863&hsaad=278483773&hsaad=278483773&hsaad=278483773&hsaad=278483773&hsaad=278483773&hsaad=278483773&hsaad=278483773&hsaad=278483773&hsaad=278483773&hsaad=278483773&hsaad=278483773&hsaad=278483773&hsanet=linkedin&hsanet=linkedin&hsanet=linkedin&hsanet=linkedin&hsanet=linkedin&hsanet=linkedin&hsanet=linkedin&hsanet=linkedin&hsanet=linkedin&hsanet=linkedin&hsanet=linkedin&hsanet=linkedin&hsaver=3&hsaver=3&hsaver=3&hsaver=3&hsaver=3&hsaver=3&hsaver=3&hsaver=3&hsaver=3&hsaver=3&hsaver=3&hsaver=3&utmcampaign=BoostPostWebsite+VisitsAug+16,+2023,+15:10:33&utmsource=linkedin&utmmedium=paid&hsaacc=506280771&hsacam=664708403&hsagrp=274867863&hsaad=278483773&hsanet=linkedin&hsaver=3

eCOA in Clinical Trials: A Game-Changer for Data Collection https://lnkd.in/dk7ND9kX Follow us #ProRelixResearch to read more informative articles like these!! #ecoinclinicaltrials #eCOA #ecoaclinicaltrials #ClinicalTrials #ProRelixResearch  #DataCollection #PatientReportedOutcomes #RealWorldEvidence #PatientCentricTrials #ClinicalData #clinicalresearch #clinicaltrials #cro #clinicaltrialsinindia #croservices #clinicalstudies #blog #blogspot #ProRelixResearch #clinicalresearchorganization #CRO 

Like most other things in life, participating in a clinical trial comes with a combination of potential advantages and disadvantages. When evaluating participating in a clinical trial, be sure to consider both. Scroll down to read an excerpt from a recent article posted on naaf.org. Access the full article here: https://ow.ly/bnTZ50Q6zW0 "In addition to having access to a possibly new medication, clinical trial volunteers have other advantages through their participation, such as having someone keeping a close eye on their health. This includes regular contact with research nurses, along with blood tests and other medical tests, depending on the drug and its potential side effects. Of course, there may be some disadvantages to participating in a clinical trial as well. If it’s a trial that compares a new drug with a placebo (an inactive medication), there is a chance you may not get the study drug at first. But Maryanne Senna, MD, Director of the Lahey Hair Loss Center of Excellence and Research Unit at Beth Israel Lahey Health and member of NAAF’s Scientific & Medical Advisory Task Force, pointed out that some studies have what is called cross-over portions. “This is where patients who were first randomized to placebo eventually get treated with the active therapy. This is worth asking if you are considering participating in a clinical trial.” The advantages of regular contact and tests could become a disadvantage if the clinic visits become too frequent or inconvenient for you, though, so you have to consider how much of your time is needed. Finally, you could experience side effects, or the study drug may not work."

Engaging patients in clinical trial participation is a necessary but often challenging step in the drug development process. Who would have ideas on how to boost the appeal of taking part in clinical trials? Patients and family caregivers themselves! This Friday, Wes Michael will share the results of a survey conducted by Rare Patient Voice of almost 2,000 patients and family caregivers on what makes them reluctant and what might make them more likely to take part. Be sure to register now for Prepare to Engage: Listening to Patients for Greater Participation in Clinical Trials, the closing webinar of Informa Engage's Patients in Clinical Trials Digital Week: https://lnkd.in/e-iKbs8D #ClinicalTrials #ClinicalResearch #PatientParticipation

🌟 Celebrating diversity in everything? Well, we're still not done - time to embrace it in Clinical trials, too🌟 In the ever-evolving realm of medical research, there's a critical challenge the industry must address: how do we balance the need for diverse patient representation with the need for efficient site performance? 🤔 This article is shedding light on the importance of incorporating diversity as a foundational aspect of clinical trial design, rather than just an afterthought. 💡 From fostering strong community partnerships to leveraging technology for accessibility, it covers actionable strategies to ensure that diversity enhances, rather than complicates, trial execution. And it's not just about theory; there are already some real-world success stories Everyone's aware of the many issues with the industry - it's about time we start revolutionizing clinical trials, making them more inclusive, efficient, and impactful for all! 🚀 #ClinicalResearch #DiversityandInclusion #InnovateClinicalTrials

Finding a clinical trial can be a daunting task - even for people who "speak the language". Laypersons have pathways, but not every pathway is easy to navigate (actually most are not). It is great to see a pathway developed that keeps the essential partner (the participant) in mind. Without making trials easy to find, how can we ever expect studies to be successful?